Horizon Space Acquisition II Corp. 10-Q — AI Bull & Bear Analysis

The 10-Q paints a picture of a SPAC in the final, high-stakes stages of its lifecycle. The tension lies between the structural safety of the Trust Account and the operational fragility of the corporate entity. While the redemption floor provides a mathematical cushion, the 'going concern' warning and the negligible cash balance indicate that the company cannot survive without the immediate closing of the SL Bio merger. Ultimately, the investment thesis has shifted from a diversified SPAC bet to a binary event. The successful closing of the merger, supported by the $7.8 million PIPE and insider loans, would validate the current trajectory. However, the extreme liquidity constraints and the tight deadline of June 18, 2026, leave virtually no room for error. Investors are essentially betting on the execution capability of the management team and the ability of SL Bio to finalize the transaction under intense time pressure.